Cambridge Capital Group (CCG) offers development funding for early stage technology based companies, primarily in Cambridge, the pre-eminent technology cluster in the UK. Occasional non technology companies are considered only if they come recommended by our network.

We are a private syndicate of angel investors and have been active since 2000, although the founders have been successful private investors in technology start-ups for the last 10 years.

In the late 1990’s the founders of Cambridge Capital Group backed Bookham Technology and nCipher in early funding rounds, both of which floated very successfully on the London Stock Exchange in 2000.

Portfolio company name change to SUMMIT PLC (previously VasTox plc): Read more...

DanioLabs Ltd. acquired by VasTox plc, an AIM listed biotech company. DanioLabs was a CCG portfolio company that has merged its zebrafish based biotech business with VasTox (in April 2007), to create a world-leading company in its field.The combined group is now called Summit plc.

 

Two recent IPO's by portfolio companies gave substantial profitable realisations to CCG members:

Bango achieved a listing on AIM in June 2005, raising £7m at a valuation of £35m.

Bango provides a technology platform as a service to content providers, enabling billing via the mobile phone operators. CCG members invested in the start-up round alongside other Cambridge based seed investors.

ITM Power, floated on AIM in June 2004 raising £10m at a valuation of £40m.

CCG investors backed this fuel cell technology company in 2002, and the potential for its hydrophilic polymer materials in new energy industries has been recognised by a consortium of institutional investors. The share price did extremely wellover the subsequent two years, giving large profits to the angel investors.